CN114392492A - Intelligent nondestructive phototherapy system - Google Patents
Intelligent nondestructive phototherapy system Download PDFInfo
- Publication number
- CN114392492A CN114392492A CN202210003888.9A CN202210003888A CN114392492A CN 114392492 A CN114392492 A CN 114392492A CN 202210003888 A CN202210003888 A CN 202210003888A CN 114392492 A CN114392492 A CN 114392492A
- Authority
- CN
- China
- Prior art keywords
- eye information
- treatment
- phototherapy
- module
- parameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/11—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils
- A61B3/112—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils for measuring diameter of pupils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
Abstract
The invention discloses an intelligent nondestructive phototherapy system, which comprises: the system comprises a monitoring module, a processing module and a phototherapy module; the monitoring module acquires first eye information and second eye information of a patient; the processing module generates current change parameters of the eyes of the patient according to the acquired first eye information and the acquired second eye information; generating a second treatment parameter according to the change parameter, the current first treatment parameter and a preset adjustment amplitude; the phototherapy module adjusts the light dose of the therapeutic light source according to the received second therapeutic parameter. The treatment using the phototherapy system of the present invention has no side effects on the patient's body.
Description
Technical Field
The invention relates to the technical field of life health, in particular to an intelligent nondestructive phototherapy system.
Background
Neurodegenerative Diseases (NDs) are a common chronic, aging disease affecting the central and peripheral nervous systems and are characterized by irreversible, progressive loss of previously intact nerve function and deterioration with age, including Alzheimer's Disease (ADs), Parkinson's Disease (PDs), and the like. Currently, the main treatment method of ND is pharmacy, but the existing drugs can only relieve symptoms and have side effects, such as diarrhea, nausea, headache and the like. In addition, treatment is not limited to medical institutions, and more importantly, daily home care, in response to the characteristics of ND.
Phototherapy (LT) is a non-invasive or minimally invasive treatment method for alleviating or treating diseases by irradiating an affected part with Light without side effects. At present, the optical therapy forms three major optical treatment technologies including strong laser treatment, photodynamic treatment and weak laser treatment, and is widely applied to the treatment of various diseases. With the shift of medical treatment modes, the disease spectrum of weak laser treatment gradually expands from common diseases to major chronic aging diseases, the treatment field also extends from disease treatment to disease prevention, and the main battlefield of the application thereof also gradually inclines from medical institutions to communities and families.
Currently, there is no weak laser treatment system for ND treatment.
Disclosure of Invention
The present invention provides an intelligent non-destructive phototherapy system for overcoming at least one technical problem in the prior art.
The embodiment of the invention provides an intelligent nondestructive phototherapy system, which comprises: the monitoring module is connected with the processing module, and the processing module is connected with the phototherapy module; the monitoring module acquires first eye information and second eye information of a patient, and sends the first eye information and the second eye information to the processing module, wherein the first eye information and the second eye information comprise pupil size and eyeball blood silk distribution condition, and the acquisition time interval of the first eye information and the second eye information is preset time period; the processing module generates a current change parameter of the patient eye according to the acquired first eye information and the acquired second eye information; generating a second treatment parameter according to the change parameter, the current first treatment parameter and a preset adjustment range, and sending the second treatment parameter to the phototherapy module; the first and second treatment parameters comprise an illumination power and an illumination frequency; the phototherapy module adjusts the light dose of the therapeutic light source according to the received second therapeutic parameter.
Optionally, the first eye information includes first time eye information and second time eye information, and the second eye information includes third time eye information and fourth time eye information; the step of generating, by the processing module, a current change parameter of the eye of the patient according to the acquired first eye information and the acquired second eye information includes: the processing module generates first eye information of the patient according to the eye information at the first time and the eye information at the second time; generating second eye information of the patient according to the eye information at the third moment and the eye information at the fourth moment; the first time, the second time, the third time and the fourth time are separated by a preset first time interval, and the second time and the third time are separated by a preset second time interval.
Optionally, the first eye information and the second eye information further include a blinking frequency; the variation parameters include: pupil variable, eyeball blood silk distribution density variable and blink frequency variable; the second treatment parameters include a third treatment parameter and a fourth treatment parameter; the step of generating a second treatment parameter according to the variation parameter, the current first treatment parameter and a preset adjustment amplitude comprises: the processing module calculates a current fitness value according to the pupil variation, the eyeball blood silk distribution density variation and the blinking frequency variation of the patient; the processing module judges whether the current first treatment parameter is matched with the patient according to the fitness value and a preset fitness value partition table; if the first treatment parameter is matched with the second treatment parameter, the processing module adjusts the preset adjustment amplitude upwards based on the first treatment parameter to generate a third treatment parameter; if not, the processing module adjusts the treatment parameters downwards according to the first treatment parameters and the preset adjustment range to generate fourth treatment parameters.
Optionally, the preset fitness value partition table includes a one-to-one correspondence relationship between intervals where a plurality of fitness values are located and evaluations, where the evaluations include adaptation, mild incompatibility, and severe incompatibility.
Optionally, the step of generating a fourth treatment parameter by the processing module adjusting the treatment parameter according to the first treatment parameter and a preset adjustment range includes: if the evaluation of the fitness value in the preset fitness value partition table is slight inadaptation, determining a preset adjustment amplitude with the actual down-regulation amplitude doubled; if the evaluation of the fitness value in the preset fitness value partition table is not suitable, determining a preset adjustment amplitude with the actual down-regulation amplitude being two times; if the evaluation of the fitness value in the preset fitness value partition table is serious inadaptation, determining a preset adjustment amplitude with the actual down-regulation amplitude being three times; and on the basis of the first treatment parameter, the actual downward regulation amplitude is adjusted downward to generate a fourth treatment parameter.
Optionally, the assessment further comprises allergy; after the step of finding the corresponding evaluation of the fitness value in a preset fitness value partition table by the processing module according to the fitness value, the method further comprises: if the assessment is allergy, the processing module sends a treatment stopping instruction to the phototherapy module; the phototherapy module turns off the therapeutic light source after receiving the therapeutic stopping instruction.
Optionally, the system further comprises an adjustment module; the adjusting module acquires a fifth treatment parameter and sends the fifth treatment parameter to the phototherapy module; the phototherapy module adjusts the illumination dosage of the light source according to the received fifth treatment parameter.
Optionally, the intelligent non-destructive phototherapy system comprises intelligent non-destructive phototherapy glasses; the treatment module is a transparent LED pulsed light lens on the intelligent lossless phototherapy glasses; the monitoring module is a super-clear monitoring camera arranged on the intelligent lossless phototherapy glasses frame.
Optionally, the processing module is a microprocessor disposed on the intelligent non-destructive phototherapy glasses; the adjusting module is arranged at the side of the intelligent lossless phototherapy glasses, and comprises an increment key for increasing the illumination dose and a decrement key for reducing the illumination dose; the micro-processor is respectively connected with the LED pulse light lens, the ultra-clear monitoring camera and the adjusting module in a wired or wireless mode.
Optionally, the intelligent non-destructive phototherapy system further comprises a remote operation terminal; the intelligent non-destructive phototherapy glasses further comprise a first communication module; the remote operation terminal is provided with the processing module, the adjusting module and a second communication module; the intelligent lossless phototherapy glasses and the remote operation terminal are connected through the first communication module and the second communication module respectively.
The innovation points of the embodiment of the invention comprise:
1. the intelligent nondestructive phototherapy system provided by the invention can be used for treating patients with Neurodegenerative Diseases (NDs) by using weak laser, and compared with drug treatment, the phototherapy system provided by the invention has no side effect on the bodies of the patients. Is one of the innovative points of the embodiment of the invention.
2. In the intelligent lossless phototherapy system provided by the invention, the processing module can monitor the eye condition of the patient in real time according to the monitoring module and automatically adjust the illumination dose of the phototherapy module according to the current eye condition of the patient, so that the intelligent lossless phototherapy system is convenient to use, safe and reliable, does not need professional skills, and is convenient for the patient to use at home. Is one of the innovative points of the embodiment of the invention.
3. In the intelligent lossless phototherapy system provided by the invention, the processing module can automatically adjust the illumination dose of the phototherapy module in stages according to the eye information of the patient in the current time period, so that the problems of discomfort of the eyes of the patient caused by large illumination dose and poor treatment effect caused by insufficient illumination dose are avoided, the experience feeling and the treatment effect of the patient are considered, and the treatment effect is improved to the maximum extent on the premise that the eyes of the patient are more comfortable. Is one of the innovative points of the embodiment of the invention.
4. The intelligent lossless phototherapy system provided by the invention is small, exquisite, convenient and portable, is suitable for household daily nursing and treatment, and particularly can be worn on the head of a patient. Is one of the innovative points of the embodiment of the invention.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the drawings without creative efforts.
Fig. 1 is an intelligent non-destructive phototherapy system according to the present invention;
FIG. 2 is another embodiment of an intelligent non-destructive phototherapy system according to the present invention;
FIG. 3 is a flowchart illustrating a specific process of step 213 in the present invention;
fig. 4 is a diagram of intelligent non-destructive phototherapy glasses according to the present invention;
fig. 5 shows the intelligent nondestructive phototherapy glasses and the remote operation terminal according to the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without inventive effort based on the embodiments of the present invention, are within the scope of the present invention.
It is to be noted that the terms "comprises" and "comprising" and any variations thereof in the embodiments and drawings of the present invention are intended to cover non-exclusive inclusions. For example, a process, method, system, article, or apparatus that comprises a list of steps or elements is not limited to only those steps or elements listed, but may alternatively include other steps or elements not listed, or inherent to such process, method, article, or apparatus.
The invention provides an intelligent nondestructive phototherapy system, and referring to fig. 1, fig. 1 is an intelligent nondestructive phototherapy system provided by the invention. As shown in fig. 1, an intelligent non-destructive phototherapy system includes: the monitoring module with processing module connects, processing module with phototherapy module connects. The interaction flow of each module in the phototherapy system is as follows:
The first eye information and the second eye information comprise pupil size and eyeball blood silk distribution conditions, and the acquisition time interval of the first eye information and the second eye information is preset time period.
In this step, the monitoring module may acquire first eye information and second eye information of the patient, where the acquisition time of the first eye information and the acquisition time of the second eye information may be separated by a preset time period, the preset time period may be 10-100 μ s, and the first eye information and the second eye information may reflect changes of eyes of the patient in the nearby time period, so as to provide a reference for determining whether a therapy parameter of the phototherapy module is appropriate in the subsequent step.
It should be noted that, the phototherapy module achieves the therapeutic effect by irradiating the eyes of the patient, and in order to monitor the eye condition of the patient in real time, the first eye information and the second eye information may include the pupil size of the patient, the distribution of blood filaments of the eyeball, and other clinical data of the patient that can reflect the degree of adaptation of the patient to the therapy of the phototherapy module.
Understandably, when the treatment parameters of the phototherapy module are inappropriate, adverse reactions such as large pupil change amplitude and eyeball telangiectasia of a patient can be caused.
In this step, the processing module can generate the change parameter that reflects the degree of reaction of the patient to the current therapeutic effect of the phototherapy module according to the first eye information and the second eye information sent by the monitoring module, so as to achieve the purpose of monitoring the eye condition of the patient in real time.
It should be noted that the variation parameter may represent the eye variation condition in the time period for acquiring the first eye information and the second eye information, that is, in the current time. If the variation parameter is larger, the eyes of the patient are not suitable for the current treatment light source, anaphylactic reaction can also occur, the illumination dose can be reduced by modifying the treatment parameter, or the phototherapy is stopped.
And 105, generating a second treatment parameter by the processing module according to the change parameter, the current first treatment parameter and a preset adjustment range, and sending the second treatment parameter to the phototherapy module.
Wherein the first and second treatment parameters include an illumination power and an illumination frequency.
In this step, the processing module can determine whether the current first treatment parameter is suitable for the patient according to the generated variation parameter, if so, then each treatment parameter can be adjusted up on the basis of the current first treatment parameter according to the preset adjustment range, if not, then each treatment parameter can be adjusted down on the basis of the first treatment parameter according to the preset adjustment range, finally, a second treatment parameter matched with the current state of the patient is obtained, and the second treatment parameter is sent to the phototherapy module, so that the phototherapy module can adjust the treatment parameter in time and adjust the illumination dose. On the one hand, under the prerequisite that patient's health can be accepted, improve the illumination dose, promote treatment, on the other hand, if the patient appears the uncomfortable reaction, then can in time reduce the illumination dose and stop the phototherapy even to improve patient's use and experience.
It should be noted that the phototherapy module may be an LED pulse light module, and the treatment parameters may include parameters that can affect the light dose of the phototherapy module, such as light power and light frequency.
In this step, the phototherapy module can adjust the treatment parameters such as the illumination power and the illumination frequency of the treatment light source according to the newly generated second treatment parameter sent by the processing module, so that the illumination dosage of the treatment light source is adapted to the eye condition of the patient, the eye allergy or the eye discomfort is avoided, and the use experience of the patient is improved.
Therefore, compared with the medicine treatment, the intelligent nondestructive phototherapy system provided by the invention has no side effect on the body of a patient; in addition, the processing module can be through monitoring module real-time supervision patient's eye condition and according to the illumination dose of patient's current eye condition automatically regulated phototherapy module, convenient to use and safe and reliable need not to possess professional skill, and the patient of being convenient for uses at home to can promote patient's use and experience.
The invention also provides another intelligent non-destructive phototherapy system, and referring to fig. 2, fig. 2 is another intelligent non-destructive phototherapy system provided by the invention. As shown in fig. 2, the processing steps of another intelligent non-destructive phototherapy system are as follows:
The first time, the second time, the third time and the fourth time are separated by a preset first time interval, and the second time and the third time are separated by a preset second time interval.
It should be noted that the first time and the second time, and the third time and the fourth time are separated by a preset first time period, and the preset first time period may be set according to practical situations, and may be set to 10 μ s in a normal case. The interval between the second time and the third time is a preset second period, and may be set to 100 μ s in general.
In this step, the processing module may generate first eye information of the patient according to the eye information at the first time and the eye information at the second time transmitted by the monitoring module, and the first eye information may be an average value of the eye information at the first time and the eye information at the second time, or may be a numerical value obtained by data processing based on the eye information at the first time and the eye information at the second time. Similarly, the second eye information is also obtained based on the eye information at the third time and the eye information at the fourth time.
It should be noted that the first eye information and the second eye information further include a blinking frequency; correspondingly, the variation parameters may include: pupil variables, eyeball blood silk distribution density variables, blink frequency variables and the like can reflect parameters of the eye adaptation degree.
And step 207, calculating the current fitness value by the processing module according to the pupil variation, the eyeball blood silk distribution density variation and the blinking frequency variation of the patient.
In this step, the processing module may calculate the current fitness value of the patient according to the pupil variation, the eyeball blood streak distribution density variation, and the blinking frequency variation of the patient.
Specifically, the formula for calculating the fitness value is as follows:
x＝50％·a+20％·b+30％·c (1)
in the formula (1), a is a pupil variable, b is an eyeball blood filament distribution density variable, and c is a blink frequency variation.
It should be noted that, the weight values corresponding to the respective variations, for example, a 50% weight value corresponding to the pupil variable, a 20% weight value corresponding to the eyeball blood streak distribution density variable, and a 30% weight value corresponding to the blinking frequency variation in the formula (1), may be adjusted according to the actual situation.
In this step, the processing module can inquire in the preset fitness value partition table according to the calculated fitness value, and judge whether the first treatment parameter currently used by the phototherapy module is matched with the eye state of the patient according to the inquiry result. If the dose is not matched, step 207 is executed to increase the dose of light of the phototherapy module in time to improve the therapeutic effect, and if the dose is not matched, step 209 is executed to decrease the dose of light in time to avoid damaging the body of the patient.
In this step, the processing module may find an evaluation corresponding to the fitness value in a preset fitness value partition table according to the calculated fitness value, so as to further determine a processing mode matched with the body of the patient.
Optionally, the preset fitness value partition table may include a one-to-one correspondence relationship between intervals where the fitness values are located and evaluations, where the evaluations may include adaptation, mild discomfort, severe discomfort, and allergy. Specifically, the preset fitness value partition table may be as shown in table 1.
| Fitness value (please fill in) | Evaluation of |
| ≥90 | Adaptation to |
| 80-90 | Mild discomfort |
| 70-80 | Is not suitable for |
| 60-70 | Severe maladaptation |
| ≤60 | Allergy (S) |
TABLE 1
Of course, in practical application, a preset fitness value partition table can be set according to the physical condition of the patient.
In this step, because the first treatment parameter that phototherapy module used at present, with patient's eye state phase-match, consequently, can be based on first treatment parameter, the adjustment range that the upregulation was predetermine generates third treatment parameter, and will third treatment parameter sends for phototherapy module can in time increase phototherapy module's illumination dosage like this under the comfortable prerequisite of patient's eye, improves treatment.
Typically, the predetermined adjustment range may be 10-40 HZ.
It should be noted that, in order to correspond to the previous embodiment, the second treatment parameter appearing in the previous embodiment may include the third treatment parameter and the fourth treatment parameter in the present embodiment.
In this step, because the first treatment parameter that phototherapy module used at present does not match with patient's eye state, consequently, can be based on first treatment parameter, the preset adjustment range of down-regulation generates fourth treatment parameter, and will fourth treatment parameter sends for phototherapy module to improve the bad state of patient's eye, avoid causing the damage to patient's health, promote patient experience.
Optionally, referring to fig. 3, fig. 3 is a flowchart of a specific processing of step 209 in the present invention, and as shown in fig. 3, step 213 may specifically include:
And a substep 32 of down-regulating said actual down-regulation amplitude on the basis of said first treatment parameter, generating a fourth treatment parameter.
Specifically, under the condition that the illumination dose of the current phototherapy module is not matched with the patient, the implementation mode of adjusting the illumination dose downwards is refined, the illumination dose is adjusted downwards in stages, evaluation is light, the downward adjustment range of the illumination dose is small, evaluation is serious, and the downward adjustment range of the illumination dose is large. Under the condition of not causing damage to the body of a patient, the treatment effect of the phototherapy module is ensured as much as possible.
Optionally, the assessment may also include allergies;
if the assessment is allergy, the processing module sends a treatment stopping instruction to the phototherapy module;
the phototherapy module turns off the therapeutic light source after receiving the therapeutic stopping instruction.
Specifically, when the corresponding evaluation of fitness value in predetermined fitness value partition table is allergic, explain that patient's eye has appeared allergic state, processing module at once to phototherapy module sends and stops the treatment instruction, and phototherapy module is receiving stop after the treatment instruction, close the treatment light source to avoid aggravating the allergic condition of patient's eye.
Specifically, the preset interval of the pupil variable may be 2.5-4mm, and when the pupil variable exceeds the preset interval, the processing module sends a treatment stopping instruction to the phototherapy module; the preset interval of the eyeball blood silk distribution density variable can be-5% -5%, and when the eyeball blood silk distribution density variable exceeds the preset interval, the processing module sends a treatment stopping instruction to the phototherapy module; the preset interval of the blink frequency variation amount can be 10-30 times/minute, and when the blink frequency variation amount is within the preset area, the processing module sends a treatment stopping instruction to the phototherapy module.
In a specific implementation, the system further comprises an adjustment module;
the adjusting module acquires a fifth treatment parameter and sends the fifth treatment parameter to the phototherapy module;
the phototherapy module adjusts the illumination dosage of the light source according to the received fifth treatment parameter.
Specifically, under some place, can be through adjustment module manual input treatment parameter, record as fifth treatment parameter, send the phototherapy module with fifth treatment parameter by the adjustment module to the phototherapy module adjusts the illumination dose of light source according to fifth treatment parameter.
Therefore, according to another intelligent lossless phototherapy system provided by the invention, the processing module can automatically adjust the illumination dose of the phototherapy module in stages according to the eye information of the patient in the current time period, so that the problems of discomfort of the eyes of the patient caused by large illumination dose and poor treatment effect caused by insufficient illumination dose are avoided, the experience feeling and the treatment effect of the patient are considered, and the treatment effect is improved to the maximum extent on the premise that the eyes of the patient are more comfortable.
In a specific implementation, the intelligent non-destructive phototherapy system provided by the invention can be specifically an intelligent non-destructive phototherapy glasses. Referring to fig. 4, fig. 4 is a view of the intelligent non-destructive phototherapy glasses proposed by the present invention.
As shown in fig. 4, the therapy module is a transparent LED pulsed light lens 401 on the intelligent lossless phototherapy glasses 40; the monitoring module is an ultra-clear monitoring camera 402 arranged on the frame of the intelligent nondestructive phototherapy glasses 40; the processing module is a microprocessor 403 arranged on the phototherapy glasses 40; the adjustment module is arranged at a side of the phototherapy glasses 40, and the adjustment module includes a button 404 for increasing the light dose, specifically includes an increment button and a decrement button.
The microprocessor 403 is respectively connected with the LED pulse light lens 401, the ultra-clear monitoring camera 402 and the adjusting module 404 in a wired or wireless manner.
Specifically, the interaction flow of the internal modules of the intelligent lossless phototherapy glasses 40 is as follows:
the super-resolution monitoring camera 402 in the intelligent lossless phototherapy glasses 40 acquires first eye information and second eye information of a patient, and sends the first eye information and the second eye information to the microprocessor 403 through the first communication module 405, where the first eye information and the second eye information include pupil size and eyeball blood silk distribution condition, and the acquisition time interval of the first eye information and the second eye information is a preset time period;
the microprocessor 403 generates a current change parameter of the eye of the patient according to the acquired first eye information and the acquired second eye information; generating a second treatment parameter according to the change parameter, the current first treatment parameter and a preset adjustment amplitude, and sending the second treatment parameter to the transparent LED pulsed light lens 401 through a second communication module; the first and second treatment parameters comprise an illumination power and an illumination frequency;
the transparent LED pulse light lens 401 adjusts the light dose of the therapeutic light source according to the received second therapeutic parameter.
For details of the processing method, reference may be made to the foregoing embodiments, which are not described herein again.
In this embodiment, intelligent harmless phototherapy glasses can solve the problem that can't real time monitoring treatment process when present therapeutic instrument is treated, can real time monitoring patient's eye condition to self-adaptation regulation light treatment dosage. In addition, intelligent harmless phototherapy glasses have the operation freedom, under the prerequisite that does not influence treatment, the patient can do other things when receiving the treatment, and convenient to use is safe, is applicable to the daily nursing at home.
In the specific implementation, the invention further provides a phototherapy intelligent device, which specifically comprises intelligent nondestructive phototherapy glasses and a remote operation terminal. Referring to fig. 5, fig. 5 illustrates the intelligent non-destructive phototherapy glasses and the remote operation terminal according to the present invention.
As shown in fig. 5, a transparent LED pulsed light lens 401, an ultra-clear monitoring camera 402 and a first communication module 405 are disposed in the phototherapy smart eye 40. The remote operation terminal 50 is provided with a processing module 501, an adjusting module 502 and a second communication module 503. The first communication module 405 is connected to the super-resolution monitoring camera 402 and the transparent LED pulse light lens 401 respectively. The second communication module 503 of the remote operation terminal 50 is wirelessly connected with the second communication module 405 of the intelligent lossless phototherapy glasses 40.
Specifically, the interaction flow between the intelligent non-destructive phototherapy glasses 40 and the remote operation terminal 50 is as follows:
the super-resolution monitoring camera 402 in the intelligent lossless phototherapy glasses 40 acquires first eye information and second eye information of a patient, and sends the first eye information and the second eye information to the processing module 501 in the remote operation terminal 50 through the first communication module 405, wherein the first eye information and the second eye information include pupil size and eyeball blood silk distribution condition, and the acquisition time interval of the first eye information and the second eye information is preset time period;
a processing module 501 in the remote operation terminal 50 generates a current change parameter of the patient's eye according to the acquired first eye information and the acquired second eye information; generating a second treatment parameter according to the change parameter, the current first treatment parameter and a preset adjustment range, and sending the second treatment parameter to a transparent LED pulse light lens 401 in the intelligent lossless phototherapy glasses 40 through a second communication module; the first and second treatment parameters comprise an illumination power and an illumination frequency;
the transparent LED pulsed light lens 401 in the intelligent lossless phototherapy glasses 40 adjusts the light dosage of the therapeutic light source according to the received second therapeutic parameter.
It should be noted that the bearing entity of the remote operation terminal 50 may be a mobile phone, a tablet, a computer, or various intelligent wearable products such as a smart watch. The functions of the remote operation terminal 50 can be implemented by various means such as APP, applet, and the like. The specific implementation of the remote operation terminal 50 is not limited herein.
For details of the processing method, reference may be made to the foregoing embodiments, which are not described herein again.
In this embodiment, compare intelligent harmless phototherapy glasses, phototherapy intelligent device's regulation is used more conveniently, and remote operation terminal 50 can undertake more personalized function settings, makes things convenient for the function expansion and the product upgrading in later stage.
Those of ordinary skill in the art will understand that: the figures are merely schematic representations of one embodiment, and the blocks or flow diagrams in the figures are not necessarily required to practice the present invention.
Those of ordinary skill in the art will understand that: modules in the devices in the embodiments may be distributed in the devices in the embodiments according to the description of the embodiments, or may be located in one or more devices different from the embodiments with corresponding changes. The modules of the above embodiments may be combined into one module, or further split into multiple sub-modules.
Finally, it should be noted that: the above examples are only intended to illustrate the technical solution of the present invention, but not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions of the embodiments of the present invention.
Claims (7)
1. An intelligent, non-destructive phototherapy system, the phototherapy system comprising: the system comprises a monitoring module, a processing module and a phototherapy module;
the monitoring module acquires first eye information and second eye information of a patient, and sends the first eye information and the second eye information to the processing module, wherein the first eye information and the second eye information comprise pupil size and eyeball blood silk distribution condition, and the acquisition time interval of the first eye information and the second eye information is preset time period;
the processing module generates a current change parameter of the patient eye according to the acquired first eye information and the acquired second eye information; generating a second treatment parameter according to the change parameter, the current first treatment parameter and a preset adjustment range, and sending the second treatment parameter to the phototherapy module; the first and second treatment parameters comprise an illumination power and an illumination frequency;
the phototherapy module adjusts the light dose of the therapeutic light source according to the received second therapeutic parameter.
2. The system of claim 1, wherein the first eye information comprises eye information at a first time and eye information at a second time, and the second eye information comprises eye information at a third time and eye information at a fourth time;
the step of generating, by the processing module, a current change parameter of the eye of the patient according to the acquired first eye information and the acquired second eye information includes:
the processing module generates first eye information of the patient according to the eye information at the first time and the eye information at the second time; generating second eye information of the patient according to the eye information at the third moment and the eye information at the fourth moment;
the first time, the second time, the third time and the fourth time are separated by a preset first time interval, and the second time and the third time are separated by a preset second time interval.
3. The system of claim 1, wherein the first eye information and second eye information further comprise a blink frequency; the variation parameters include: pupil variable, eyeball blood silk distribution density variable and blink frequency variable; the second treatment parameters include a third treatment parameter and a fourth treatment parameter;
the step of generating a second treatment parameter according to the variation parameter, the current first treatment parameter and a preset adjustment amplitude comprises:
the processing module calculates a current fitness value according to the pupil variation, the eyeball blood silk distribution density variation and the blinking frequency variation of the patient;
the processing module judges whether the current first treatment parameter is matched with the patient according to the fitness value and a preset fitness value partition table;
if the first treatment parameter is matched with the second treatment parameter, the processing module adjusts the preset adjustment amplitude upwards based on the first treatment parameter to generate a third treatment parameter; if not, the processing module adjusts the treatment parameters downwards according to the first treatment parameters and the preset adjustment range to generate fourth treatment parameters.
4. The system according to claim 3, wherein the predetermined fitness value partition table comprises a one-to-one correspondence relationship between a plurality of fitness values and evaluations, wherein the evaluations comprise adaptation, mild adaptation, non-adaptation and severe adaptation.
5. The system of claim 4, wherein the step of generating a fourth treatment parameter by the processing module adjusting the treatment parameter according to the first treatment parameter and a preset adjustment range comprises:
if the evaluation of the fitness value in the preset fitness value partition table is slight inadaptation, determining a preset adjustment amplitude with the actual down-regulation amplitude doubled; if the evaluation of the fitness value in the preset fitness value partition table is not suitable, determining a preset adjustment amplitude with the actual down-regulation amplitude being two times; if the evaluation of the fitness value in the preset fitness value partition table is serious inadaptation, determining a preset adjustment amplitude with the actual down-regulation amplitude being three times;
and on the basis of the first treatment parameter, the actual downward regulation amplitude is adjusted downward to generate a fourth treatment parameter.
6. The system of claim 5, wherein the assessment further comprises an allergy;
after the step of finding the corresponding evaluation of the fitness value in a preset fitness value partition table by the processing module according to the fitness value, the method further comprises:
if the assessment is allergy, the processing module sends a treatment stopping instruction to the phototherapy module;
the phototherapy module turns off the therapeutic light source after receiving the therapeutic stopping instruction.
7. The system of claim 1, further comprising an adjustment module;
the adjusting module acquires a fifth treatment parameter and sends the fifth treatment parameter to the phototherapy module;
the phototherapy module adjusts the illumination dosage of the light source according to the received fifth treatment parameter.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210003888.9A CN114392492B (en) | 2022-01-05 | 2022-01-05 | Intelligent nondestructive phototherapy system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210003888.9A CN114392492B (en) | 2022-01-05 | 2022-01-05 | Intelligent nondestructive phototherapy system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114392492A true CN114392492A (en) | 2022-04-26 |
| CN114392492B CN114392492B (en) | 2023-02-10 |
Family
ID=81229055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210003888.9A Active CN114392492B (en) | 2022-01-05 | 2022-01-05 | Intelligent nondestructive phototherapy system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114392492B (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6669651B1 (en) * | 2000-02-24 | 2003-12-30 | Matsushita Electric Works, Ltd. | Non-invasive brain function examination |
| US20050256545A1 (en) * | 2004-05-11 | 2005-11-17 | Steve Koh | System and method for evaluating heart failure using an implantable medical device based on heart rate during patient activity |
| UA77510U (en) * | 2012-12-24 | 2013-02-11 | Владимир Ильич Черний | Method for assessing severity of preeclampsia in pregnant patients and efficacy of therapy in dynamics |
| CN104189997A (en) * | 2014-07-25 | 2014-12-10 | 深圳市艾尔曼医疗电子仪器有限公司 | Intelligent feedback high-potential therapeutic apparatus and therapeutic method |
| US20160374594A1 (en) * | 2015-06-26 | 2016-12-29 | Koninklijke Philips N.V. | System for monitoring a dopaminergic activity |
| CN109965870A (en) * | 2019-02-27 | 2019-07-05 | 杭州诺为医疗技术有限公司 | A kind of method of automatic detection and stimulation therapy epilepsy |
| CN111414027A (en) * | 2020-04-30 | 2020-07-14 | 厦门中翎易优创科技有限公司 | Temperature therapeutic instrument capable of automatically adjusting temperature |
| CN113181016A (en) * | 2021-05-13 | 2021-07-30 | 云南白药集团无锡药业有限公司 | Eye adjustment training lamp with dynamically-changed illumination |
| CN113693612A (en) * | 2021-08-16 | 2021-11-26 | 深圳大学 | Senile dementia diagnosis and treatment device |
| CN113713256A (en) * | 2021-09-03 | 2021-11-30 | 重庆极治医疗科技有限公司 | Electric field cancer treatment equipment with feedback mechanism and diagnosis function and method |
-
2022
- 2022-01-05 CN CN202210003888.9A patent/CN114392492B/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6669651B1 (en) * | 2000-02-24 | 2003-12-30 | Matsushita Electric Works, Ltd. | Non-invasive brain function examination |
| US20050256545A1 (en) * | 2004-05-11 | 2005-11-17 | Steve Koh | System and method for evaluating heart failure using an implantable medical device based on heart rate during patient activity |
| UA77510U (en) * | 2012-12-24 | 2013-02-11 | Владимир Ильич Черний | Method for assessing severity of preeclampsia in pregnant patients and efficacy of therapy in dynamics |
| CN104189997A (en) * | 2014-07-25 | 2014-12-10 | 深圳市艾尔曼医疗电子仪器有限公司 | Intelligent feedback high-potential therapeutic apparatus and therapeutic method |
| US20160374594A1 (en) * | 2015-06-26 | 2016-12-29 | Koninklijke Philips N.V. | System for monitoring a dopaminergic activity |
| CN109965870A (en) * | 2019-02-27 | 2019-07-05 | 杭州诺为医疗技术有限公司 | A kind of method of automatic detection and stimulation therapy epilepsy |
| CN111414027A (en) * | 2020-04-30 | 2020-07-14 | 厦门中翎易优创科技有限公司 | Temperature therapeutic instrument capable of automatically adjusting temperature |
| CN113181016A (en) * | 2021-05-13 | 2021-07-30 | 云南白药集团无锡药业有限公司 | Eye adjustment training lamp with dynamically-changed illumination |
| CN113693612A (en) * | 2021-08-16 | 2021-11-26 | 深圳大学 | Senile dementia diagnosis and treatment device |
| CN113713256A (en) * | 2021-09-03 | 2021-11-30 | 重庆极治医疗科技有限公司 | Electric field cancer treatment equipment with feedback mechanism and diagnosis function and method |
Non-Patent Citations (1)
| Title |
|---|
| 魏勋斌等: "神经退行性疾病的光学疗法及其应用展望", 《中国工程科学》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114392492B (en) | 2023-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10293158B2 (en) | Controlling ear stimulation in response to a status of a subject | |
| JP7269010B2 (en) | Methods and systems for stimulating the brain | |
| US20200147340A1 (en) | Systems and methods for transdermal electrical stimulation to improve sleep | |
| EP3551145B1 (en) | Systems and methods for treating neurological disorders | |
| US10039928B2 (en) | Ear stimulation with neural feedback sensing | |
| US20190192856A1 (en) | Methods and systems to diagnose depression | |
| US9233244B2 (en) | Transdermal electrical stimulation devices for modifying or inducing cognitive state | |
| US20220016413A1 (en) | Wearable neurostimulation system with curated therapy | |
| US20170113057A1 (en) | Multi-factor control of ear stimulation | |
| US20170027812A1 (en) | Nerve stimulation system and related controller | |
| US20170113042A1 (en) | Controlling ear stimulation in response to image analysis | |
| EP3274047A1 (en) | Ear stimulation method and system | |
| US10512783B2 (en) | User interface method and system for ear stimulation | |
| US10398902B2 (en) | Neural stimulation method and system with audio output | |
| US20090005837A1 (en) | Method and apparatus for stimulating the neurochemistry of the brain resulting in increased overall brain function, cognitive performance, and intelligence quota | |
| WO2019153968A1 (en) | Method and apparatus for configuring and regulating light emission parameters of biological rhythm illumination apparatus | |
| WO2019175289A1 (en) | Pulsed electromagnetic field device and method of treatment | |
| US20200077939A1 (en) | Autonomous multisensory apparatus for screening and therapy of visual, auditory and cognitive impairment with diagnostic capability and method thereof | |
| CN114392492B (en) | Intelligent nondestructive phototherapy system | |
| CN114392496B (en) | Acousto-optic intelligent nondestructive bone conduction treatment system | |
| CN218010658U (en) | Intelligent lossless phototherapy glasses | |
| CN115068770A (en) | Neurostimulation system for non-invasive multi-sensory signals | |
| CN114464293A (en) | Sensory stimulation cognitive disorder rehabilitation training system | |
| US20190321582A1 (en) | Method and Device for Controlling Electrical Stimulation Therapeutic Apparatus | |
| WO2022059757A1 (en) | Device and method for inhibiting choroidal thinning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |